Trade Summary

Yesterday, Kirn David, serving as See Remarks at 4D Molecular Therapeutics, Inc. (FDMT), sold 12,415 shares at $10.05 per share, for a total transaction value of $124,722.33. Following this transaction, Kirn David now holds 871,737 shares of FDMT.

This sale represents a 1.40% decrease in Kirn David's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, August 3, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, August 4, 2026 at 4:45 PM ET, 1 day after the trade was made.

4D Molecular Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.